These processes drive disease progression in conditions such as psoriasis, inflammatory bowel disease (IBD), and rheumatoid arthritis
(n = 8/group) C) 30 nmol/kg tirzepatide in WT mice treated with an antagonist for the GLP-1R (Jant-4), GIPR, or both
Hearing, vision, and sensory input Hearing and vision are now central to the dementia-prevention conversation
This discovery led to the development of exenatide, the first GLP-1 receptor agonist approved for type 2 diabetes in 2005
If you have too much of the "spent" version and not enough of the "active" version, your cellular defenses may be lowered
In the periphery, GLP-1 acts directly on pancreatic islets to enhance GSIS (Mojsov et al., 1987) and inhibit glucagon release (Komatsu et al., 1989)